Skip to main content

Table 2 The prevalence of cigarette, waterpipe, and pipe users in the Tehran Cohort Study

From: Epidemiology and prevalence of tobacco use in Tehran; a report from the recruitment phase of Tehran cohort study

 

Cigarette

Waterpipe

Pipe

Characteristic

Former smoker (n = 350)

Current smoker (n = 1231)

Former user (n = 44)

Current user (n = 449)

Former user (n = 9)

Current user (n = 44)

Age, year

60.6 ± 13.00

53.2 ± 11.88

54.4 ± 16.69

46.1 ± 10.91

54.2 ± 15.86

55.1 ± 12.88

Age category, year

 35–44

49 (2.1)

343 (14.8)

19 (0.8)

259 (11.2)

4 (0.2)

10 (0.4)

 45–54

67 (3.0)

345 (15.7)

5 (0.2)

91 (4.1)

1 (0.0)

10 (0.5)

 55–64

83 (4.2)

319 (16.3)

6 (0.3)

65 (3.3)

1 (0.1)

16 (0.8)

 65–74

103 (8.5)

173 (14.4)

6 (0.5)

24 (2.0)

2 (0.2)

4 (0.3)

  ≥ 75

48 (8.5)

51 (9.1)

8 (1.4)

10 (1.8)

1 (0.2)

4 (0.7)

Sex

 Women

40 (0.9)

219 (4.9)

12 (0.3)

148 (3.3)

0 (0.0)

5 (0.1)

 Men

310 (8.2)

1012 (26.8)

32 (0.8)

301 (7.9)

9 (0.2)

39 (1.0)

Marital status

 Non-married

4 (6.0)

5 (7.5)

2 (3.0)

4 (6.1)

0 (0.0)

0 (0.0)

 Married

346 (4.2)

1225 (15.0)

41 (0.5)

445 (5.4)

9 (0.1)

44 (0.5)

Education, year

 Illiterate

26 (4.5)

47 (8.1)

6 (1.0)

11 (1.9)

0 (0.0)

1 (0.2)

 1–5

42 (5.0)

100 (12.0)

6 (0.7)

29 (3.5)

0 (0.0)

1 (0.1)

 6–12

190 (4.4)

722 (16.8)

21 (0.5)

259 (6.0)

2 (0.0)

18 (0.4)

  > 12

92 (3.6)

361 (14.3)

10 (0.4)

150 (5.9)

7 (0.3)

24 (0.9)

Body mass index, kg/m2

  < 20

8 (3.6)

67 (29.8)

0 (0.0)

5 (2.2)

0 (0.0)

1 (0.4)

 20–24.9

88 (4.3)

384 (18.6)

12 (0.6)

101 (4.9)

0 (0.0)

11 (0.5)

 25–29.9

151 (4.4)

500 (14.6)

20 (0.6)

202 (5.9)

7 (0.2)

21 (0.6)

 30–34.9

71 (4.0)

208 (11.6)

10 (0.6)

107 (6.0)

1 (0.1)

5 (0.3)

  ≥ 35

27 (4.0)

64 (9.4)

2 (0.3)

33 (4.8)

1 (0.1)

5 (0.7)

Physical activity

 Low

77 (5.3)

206 (14.3)

11 (0.8)

44 (3.0)

2 (0.1)

7 (0.5)

 Intermediate

181 (3.8)

666 (14.0)

26 (0.5)

253 (5.3)

5 (0.1)

15 (0.3)

 High

91 (4.6)

336 (16.9)

6 (0.3)

146 (7.3)

2 (0.1)

19 (1.0)

Opium consumption

 No

283 (3.6)

946 (12.2)

35 (0.4)

414 (5.3)

4 (0.1)

35 (0.4)

 Yes

65 (14.9)

269 (61.6)

9 (2.1)

30 (6.9)

5 (1.1)

9 (2.1)

Alcohol consumption

 No

256 (3.4)

888 (11.9)

25 (0.3)

308 (4.1)

1 (0.0)

29 (0.4)

 Yes

91 (12.4)

330 (44.8)

19 (2.6)

138 (18.8)

7 (1.0)

14 (1.9)

Hypertension

 No

210 (3.5)

969 (16.4)

28 (0.5)

385 (6.5)

6 (0.1)

31 (0.5)

 Yes

140 (6.1)

261 (11.3)

16 (0.7)

64 (2.8)

3 (0.1)

13 (0.6)

Diabetes mellitus

 No

272 (3.9)

1077 (15.5)

40 (0.6)

398 (5.7)

6 (0.1)

40 (0.6)

 Yes

78 (6.1)

153 (11.9)

4 (0.3)

51 (4.0)

3 (0.2)

4 (0.3)

Dyslipidemia

 No

206 (3.7)

889 (16.0)

31 (0.6)

347 (6.2)

4 (0.1)

28 (0.5)

 Yes

144 (5.4)

341 (12.7)

13 (0.5)

102 (3.8)

5 (0.2)

16 (0.6)

Chronic kidney disease

 No

339 (4.2)

1224 (15.0)

44 (0.5)

446 (5.5)

9 (0.1)

44 (0.5)

 Yes

11 (15.5)

7 (9.9)

0 (0.0)

3 (4.2)

0 (0.0)

0 (0.0)

Chronic lung disease

 No

330 (4.1)

1195 (15)

40 (0.5)

438 (5.5)

8 (0.1)

43 (0.5)

 Yes

20 (7.5)

36 (13.6)

4 (1.5)

11 (4.1)

1 (0.4)

1 (0.4)

Coronary artery disease

 No

258 (3.5)

1103 (14.8)

39 (0.5)

433 (5.8)

8 (0.1)

34 (0.5)

 Yes

92 (12.0)

128 (16.7)

5 (0.7)

16 (2.1)

1 (0.1)

10 (1.3)

  1. Data are presented as mean ± standard deviation for continuous and number (percentage calculated for rows) for categorical variables